149 related articles for article (PubMed ID: 22092682)
1. BopC is a type III secreted effector protein of Burkholderia pseudomallei.
Muangman S; Korbsrisate S; Muangsombut V; Srinon V; Adler NL; Schroeder GN; Frankel G; Galyov EE
FEMS Microbiol Lett; 2011 Oct; 323(1):75-82. PubMed ID: 22092682
[TBL] [Abstract][Full Text] [Related]
2. Functional characterizations of effector protein BipC, a type III secretion system protein, in Burkholderia pseudomallei pathogenesis.
Kang WT; Vellasamy KM; Chua EG; Vadivelu J
J Infect Dis; 2015 Mar; 211(5):827-34. PubMed ID: 25165162
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of the intracellular survival of the Burkholderia pseudomallei bopC mutant.
Srinon V; Muangman S; Imyaem N; Muangsombut V; Lazar Adler NR; Galyov EE; Korbsrisate S
J Microbiol; 2013 Aug; 51(4):522-6. PubMed ID: 23990305
[TBL] [Abstract][Full Text] [Related]
4. Identification of a regulatory cascade controlling Type III Secretion System 3 gene expression in Burkholderia pseudomallei.
Sun GW; Chen Y; Liu Y; Tan GY; Ong C; Tan P; Gan YH
Mol Microbiol; 2010 May; 76(3):677-89. PubMed ID: 20345664
[TBL] [Abstract][Full Text] [Related]
5. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
Warawa J; Woods DE
FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic analysis of Burkholderia pseudomallei Bsa type III secretion system effectors using hypersecreting mutants.
Vander Broek CW; Chalmers KJ; Stevens MP; Stevens JM
Mol Cell Proteomics; 2015 Apr; 14(4):905-16. PubMed ID: 25635268
[TBL] [Abstract][Full Text] [Related]
7. Type III Secretion in the Melioidosis Pathogen
Vander Broek CW; Stevens JM
Front Cell Infect Microbiol; 2017; 7():255. PubMed ID: 28664152
[No Abstract] [Full Text] [Related]
8. Inactivation of Burkholderia pseudomallei bsaQ results in decreased invasion efficiency and delayed escape of bacteria from endocytic vesicles.
Muangsombut V; Suparak S; Pumirat P; Damnin S; Vattanaviboon P; Thongboonkerd V; Korbsrisate S
Arch Microbiol; 2008 Dec; 190(6):623-31. PubMed ID: 18654761
[TBL] [Abstract][Full Text] [Related]
9. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?
Lazar Adler NR; Govan B; Cullinane M; Harper M; Adler B; Boyce JD
FEMS Microbiol Rev; 2009 Nov; 33(6):1079-99. PubMed ID: 19732156
[TBL] [Abstract][Full Text] [Related]
10. Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter.
Charpentier X; Oswald E
J Bacteriol; 2004 Aug; 186(16):5486-95. PubMed ID: 15292151
[TBL] [Abstract][Full Text] [Related]
11. Production and purification of Burkholderia pseudomallei BipD protein.
Visutthi M; Jitsurong S; Chotigeat W
Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):109-14. PubMed ID: 18567449
[TBL] [Abstract][Full Text] [Related]
12. In silico prediction of host-pathogen protein interactions in melioidosis pathogen Burkholderia pseudomallei and human reveals novel virulence factors and their targets.
Loaiza CD; Duhan N; Lister M; Kaundal R
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32444871
[TBL] [Abstract][Full Text] [Related]
13. BipC, a Predicted
Vander Broek CW; Zainal Abidin N; Stevens JM
Front Cell Infect Microbiol; 2017; 7():333. PubMed ID: 28770177
[No Abstract] [Full Text] [Related]
14. The mviN homolog in Burkholderia pseudomallei is essential for viability and virulence.
Ling JM; Moore RA; Surette MG; Woods DE
Can J Microbiol; 2006 Sep; 52(9):831-42. PubMed ID: 17110975
[TBL] [Abstract][Full Text] [Related]
15. CesT is a multi-effector chaperone and recruitment factor required for the efficient type III secretion of both LEE- and non-LEE-encoded effectors of enteropathogenic Escherichia coli.
Thomas NA; Deng W; Puente JL; Frey EA; Yip CK; Strynadka NC; Finlay BB
Mol Microbiol; 2005 Sep; 57(6):1762-79. PubMed ID: 16135239
[TBL] [Abstract][Full Text] [Related]
16. A type IV pilin, PilA, Contributes To Adherence of Burkholderia pseudomallei and virulence in vivo.
Essex-Lopresti AE; Boddey JA; Thomas R; Smith MP; Hartley MG; Atkins T; Brown NF; Tsang CH; Peak IR; Hill J; Beacham IR; Titball RW
Infect Immun; 2005 Feb; 73(2):1260-4. PubMed ID: 15664977
[TBL] [Abstract][Full Text] [Related]
17. The Burkholderia pseudomallei Proteins BapA and BapC Are Secreted TTSS3 Effectors and BapB Levels Modulate Expression of BopE.
Treerat P; Alwis P; D'Cruze T; Cullinane M; Vadivelu J; Devenish RJ; Prescott M; Adler B; Boyce JD
PLoS One; 2015; 10(12):e0143916. PubMed ID: 26624293
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Brucella spp. secreted effector specifically interacting with human small GTPase Rab2.
de Barsy M; Jamet A; Filopon D; Nicolas C; Laloux G; Rual JF; Muller A; Twizere JC; Nkengfac B; Vandenhaute J; Hill DE; Salcedo SP; Gorvel JP; Letesson JJ; De Bolle X
Cell Microbiol; 2011 Jul; 13(7):1044-58. PubMed ID: 21501366
[TBL] [Abstract][Full Text] [Related]
19. The Bordetella Secreted Regulator BspR Is Translocated into the Nucleus of Host Cells via Its N-Terminal Moiety: Evaluation of Bacterial Effector Translocation by the Escherichia coli Type III Secretion System.
Abe A; Nishimura R; Tanaka N; Kurushima J; Kuwae A
PLoS One; 2015; 10(8):e0135140. PubMed ID: 26247360
[TBL] [Abstract][Full Text] [Related]
20. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen.
Stevens MP; Wood MW; Taylor LA; Monaghan P; Hawes P; Jones PW; Wallis TS; Galyov EE
Mol Microbiol; 2002 Nov; 46(3):649-59. PubMed ID: 12410823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
